Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […]
Phathom Pharmaceuticals (PHAT) to Release Quarterly Earnings on Thursday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $26.00 price target on the stock. Phathom Pharmaceuticals Stock Up 1.9 % PHAT stock opened at $9.35 on Friday. The stock has a market capitalization […]
Brokerages Set Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) PT at $23 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 8,190,000 shares, a growth of 15.7% from the December 31st total of 7,080,000 shares. Approximately 30.8% of the company’s stock are short sold. Based on an […]